4.5 Article

Psychiatric and Medical Comorbidities: Results from a Bipolar Elderly Cohort Study

Journal

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Volume 22, Issue 11, Pages 1066-1074

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jagp.2013.12.176

Keywords

Somatic; medical; psychiatric; comorbidity; bipolar; elderly

Funding

  1. Eli Lilly
  2. Astra Zeneca
  3. Jansen and Shire
  4. AstraZeneca
  5. Pfizer
  6. Merck
  7. Ortho-McNeil Janssen

Ask authors/readers for more resources

Objective: Bipolar disorder is associated with concurrent mental and physical disorders. Although well studied among younger adults, less is known about concurrent morbidity among older patients. This is important because comorbidity may increase with age and optimal treatment requires awareness of medical and psychiatric comorbidities. This study analyzed psychiatric and medical comorbidity in a Dutch bipolar elderly cohort. Methods: This cross-sectional descriptive study included demographic and clinical data on 101 bipolar patients aged 60 and over (mean age: 68.9 +/- 7.8 years); 53.4% were women. Psychiatric diagnoses were confirmed by semi-structured diagnostic interviews. Somatic history, including current somatic complaints, was obtained by interview. Medication and indicators of metabolic syndrome were obtained via record review. Results: Most patients received outpatient care. Bipolar I disorder was diagnosed in 56.4% of patients, and 75.6% had an onset of first affective symptoms before age 50. The prevalence rates of psychiatric comorbidities were low, except for lifetime alcohol dependence (24.8%) and abuse (13.9%). On average, there were 1.7 (SD: 1.6) medical comorbid conditions, predominantly hypertension (27.8%), arthrosis (29.1%), and allergies (25.6%). Polypharmacy was found in 31.7% of patients and metabolic syndrome in 28.7%. Conclusion: Psychiatric comorbidity (especially anxiety disorders) was relatively uncommon, except for substance use disorder. Geriatric bipolar patients had on average two comorbid medical conditions and relatively high medication use. Findings underline the need to assess for comorbid conditions in bipolar elders, thereby enabling tailored treatment to optimize the general condition of these patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available